The second pure-player device maker on our list literally has its origins in the basement of a Massachusetts church, co-founder John Abele told us. Boston Scientific leveraged its early lead in the catheter space into market- leading footprints in the coronary stent, endovascular, neuromodulation and cardiac rhythm management arenas. Incoming CEO Michael Mahoney, a Johnson & Johnson lifer, is slated to take the helm in fall 2012.
Home » Boston Scientific